Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
CenterPoint Energy, Inc. stock logo
CNP
CenterPoint Energy
$38.99
+1.0%
$36.07
$25.41
$39.18
$25.45B0.655.57 million shs3.80 million shs
Entergy Corporation stock logo
ETR
Entergy
$84.47
+1.3%
$83.33
$52.07
$88.38
$36.39B0.563.68 million shs2.92 million shs
Exelon Co. stock logo
EXC
Exelon
$46.48
-0.3%
$45.06
$34.01
$48.11
$46.92B0.397.28 million shs5.88 million shs
Pfizer Inc. stock logo
PFE
Pfizer
$24.19
+1.1%
$24.34
$20.92
$31.54
$137.19B0.6740.57 million shs41.67 million shs
Seagen Inc. stock logo
SGEN
Seagen
$228.74
$228.74
$123.77
$228.96
$42.93B0.321.48 million shs86 shs
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
$102.08
+0.3%
$105.53
$93.10
$122.25
$20.14B0.781.66 million shs3.28 million shs
5G Stocks: The Path Forward is Profitable Cover

Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
CenterPoint Energy, Inc. stock logo
CNP
CenterPoint Energy
+0.98%+2.15%+5.49%+19.79%+32.94%
Entergy Corporation stock logo
ETR
Entergy
+1.25%-0.15%-2.54%+4.07%+57.92%
Exelon Co. stock logo
EXC
Exelon
-0.26%+0.56%+1.11%+16.20%+22.83%
Pfizer Inc. stock logo
PFE
Pfizer
+1.18%+5.40%-2.18%-8.73%-10.97%
Seagen Inc. stock logo
SGEN
Seagen
0.00%0.00%0.00%0.00%0.00%
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
+0.18%+0.61%-9.29%-6.66%-14.62%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
CenterPoint Energy, Inc. stock logo
CNP
CenterPoint Energy
3.3367 of 5 stars
2.22.02.51.43.51.70.6
Entergy Corporation stock logo
ETR
Entergy
4.2341 of 5 stars
2.45.01.72.43.41.71.3
Exelon Co. stock logo
EXC
Exelon
4.3315 of 5 stars
2.23.02.53.34.02.51.3
Pfizer Inc. stock logo
PFE
Pfizer
4.9794 of 5 stars
3.33.04.24.33.23.33.1
Seagen Inc. stock logo
SGEN
Seagen
N/AN/AN/AN/AN/AN/AN/AN/A
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
4.7608 of 5 stars
3.25.01.73.73.62.51.3
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
CenterPoint Energy, Inc. stock logo
CNP
CenterPoint Energy
2.43
Hold$35.79-8.20% Downside
Entergy Corporation stock logo
ETR
Entergy
2.80
Moderate Buy$85.751.52% Upside
Exelon Co. stock logo
EXC
Exelon
2.44
Hold$48.223.75% Upside
Pfizer Inc. stock logo
PFE
Pfizer
2.53
Moderate Buy$29.1720.57% Upside
Seagen Inc. stock logo
SGEN
Seagen
0.00
N/AN/AN/A
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
2.32
Hold$124.1521.62% Upside

Current Analyst Ratings Breakdown

Latest EXC, ETR, CNP, PFE, ZBH, and SGEN Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/2/2025
Exelon Co. stock logo
EXC
Exelon
Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetEqual Weight ➝ Equal Weight$46.00 ➝ $50.00
5/2/2025
Exelon Co. stock logo
EXC
Exelon
Guggenheim
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$47.00 ➝ $50.00
5/2/2025
Exelon Co. stock logo
EXC
Exelon
Evercore ISI
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetIn-Line ➝ In-Line$48.00 ➝ $51.00
5/1/2025
Entergy Corporation stock logo
ETR
Entergy
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$88.00 ➝ $91.00
4/30/2025
Entergy Corporation stock logo
ETR
Entergy
BMO Capital Markets
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOutperform ➝ Outperform$89.00 ➝ $93.00
4/30/2025
Pfizer Inc. stock logo
PFE
Pfizer
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetNeutral ➝ Neutral$24.00 ➝ $25.00
4/28/2025
CenterPoint Energy, Inc. stock logo
CNP
CenterPoint Energy
Evercore ISI
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOutperform ➝ Outperform$37.00 ➝ $41.00
4/28/2025
Exelon Co. stock logo
EXC
Exelon
BMO Capital Markets
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOutperform ➝ Outperform$46.00 ➝ $50.00
4/25/2025
CenterPoint Energy, Inc. stock logo
CNP
CenterPoint Energy
Scotiabank
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOutperform ➝ Outperform$35.00 ➝ $40.00
4/23/2025
Entergy Corporation stock logo
ETR
Entergy
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Overweight
4/23/2025
CenterPoint Energy, Inc. stock logo
CNP
CenterPoint Energy
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOutperform ➝ Outperform
(Data available from 5/3/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
CenterPoint Energy, Inc. stock logo
CNP
CenterPoint Energy
$8.94B2.85$4.40 per share8.86$16.37 per share2.38
Entergy Corporation stock logo
ETR
Entergy
$11.88B3.06$9.24 per share9.14$35.04 per share2.41
Exelon Co. stock logo
EXC
Exelon
$23.03B2.04$6.54 per share7.11$26.78 per share1.74
Pfizer Inc. stock logo
PFE
Pfizer
$62.46B2.20$3.79 per share6.38$15.81 per share1.53
Seagen Inc. stock logo
SGEN
Seagen
$2.30B18.66N/AN/A$15.10 per share15.15
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
$7.68B2.63$13.00 per share7.85$62.67 per share1.63
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
CenterPoint Energy, Inc. stock logo
CNP
CenterPoint Energy
$917M$1.4924.5220.852.7111.79%10.02%2.48%N/A
Entergy Corporation stock logo
ETR
Entergy
$2.36B$2.4334.6919.642.348.90%10.68%2.49%N/A
Exelon Co. stock logo
EXC
Exelon
$2.46B$2.4518.9716.722.8610.68%9.52%2.38%N/A
Pfizer Inc. stock logo
PFE
Pfizer
$8.03B$1.3817.167.980.6412.62%19.47%8.09%N/A
Seagen Inc. stock logo
SGEN
Seagen
-$610.31M-$4.01N/AN/AN/A-32.61%-28.06%-20.92%N/A
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
$903.70M$4.4522.9411.511.9511.77%12.99%7.58%5/5/2025 (Estimated)

Latest EXC, ETR, CNP, PFE, ZBH, and SGEN Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/5/2025Q1 2025
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
$1.77N/AN/AN/A$1.89 billionN/A
5/1/2025Q1 2025
Exelon Co. stock logo
EXC
Exelon
$0.86$0.92+$0.06$0.90$6.30 billion$6.71 billion
4/29/2025Q1 2025
Entergy Corporation stock logo
ETR
Entergy
$0.60$0.82+$0.22$0.82$3.13 billion$3.02 billion
4/29/2025Q1 2025
Pfizer Inc. stock logo
PFE
Pfizer
$0.67$0.92+$0.25$0.52$14.43 billion$13.72 billion
4/24/2025Q1 2025
CenterPoint Energy, Inc. stock logo
CNP
CenterPoint Energy
$0.55$0.53-$0.02$0.45$2.73 billion$2.92 billion
2/20/2025Q4 2024
CenterPoint Energy, Inc. stock logo
CNP
CenterPoint Energy
$0.40$0.40N/A$0.38$2.46 billion$2.26 billion
2/18/2025Q4 2024
Entergy Corporation stock logo
ETR
Entergy
$0.63$0.66+$0.03$0.65$3.24 billion$2.74 billion
2/12/2025Q4 2024
Exelon Co. stock logo
EXC
Exelon
$0.59$0.64+$0.05$0.64$5.44 billionN/A
2/6/2025Q4 2024
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
$2.30$2.31+$0.01$1.20$2.01 billionN/A
2/4/2025Q4 2024
Pfizer Inc. stock logo
PFE
Pfizer
$0.48$0.63+$0.15$0.07$17.26 billion$17.76 billion
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
CenterPoint Energy, Inc. stock logo
CNP
CenterPoint Energy
$0.882.26%+7.61%59.06%N/A
Entergy Corporation stock logo
ETR
Entergy
$2.402.84%+5.94%98.77%N/A
Exelon Co. stock logo
EXC
Exelon
$1.603.44%-0.22%65.31%N/A
Pfizer Inc. stock logo
PFE
Pfizer
$1.727.11%+2.50%124.64%16 Years
Seagen Inc. stock logo
SGEN
Seagen
N/AN/AN/AN/AN/A
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
$0.960.94%N/A21.57%N/A

Latest EXC, ETR, CNP, PFE, ZBH, and SGEN Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
4/29/2025
Exelon Co. stock logo
EXC
Exelon
quarterly$0.403.41%5/12/20255/12/20256/13/2025
4/23/2025
Pfizer Inc. stock logo
PFE
Pfizer
quarterly$0.437.69%5/9/20255/9/20256/13/2025
4/16/2025
CenterPoint Energy, Inc. stock logo
CNP
CenterPoint Energy
quarterly$0.222.39%5/15/20255/15/20256/12/2025
4/7/2025
Entergy Corporation stock logo
ETR
Entergy
quarterly$0.603.03%5/2/20255/2/20256/2/2025
2/26/2025
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
quarterly$0.240.89%3/31/20253/31/20254/30/2025
2/12/2025
Exelon Co. stock logo
EXC
Exelon
quarterly$0.403.7%2/24/20252/24/20253/14/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
CenterPoint Energy, Inc. stock logo
CNP
CenterPoint Energy
1.91
1.08
0.92
Entergy Corporation stock logo
ETR
Entergy
1.81
0.72
0.59
Exelon Co. stock logo
EXC
Exelon
1.61
0.87
0.78
Pfizer Inc. stock logo
PFE
Pfizer
0.63
1.00
0.73
Seagen Inc. stock logo
SGEN
Seagen
N/A
2.67
2.12
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
0.43
1.91
0.99

Institutional Ownership

CompanyInstitutional Ownership
CenterPoint Energy, Inc. stock logo
CNP
CenterPoint Energy
91.77%
Entergy Corporation stock logo
ETR
Entergy
88.07%
Exelon Co. stock logo
EXC
Exelon
80.92%
Pfizer Inc. stock logo
PFE
Pfizer
68.36%
Seagen Inc. stock logo
SGEN
Seagen
84.26%
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
88.89%

Insider Ownership

CompanyInsider Ownership
CenterPoint Energy, Inc. stock logo
CNP
CenterPoint Energy
0.14%
Entergy Corporation stock logo
ETR
Entergy
0.39%
Exelon Co. stock logo
EXC
Exelon
0.10%
Pfizer Inc. stock logo
PFE
Pfizer
0.06%
Seagen Inc. stock logo
SGEN
Seagen
25.90%
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
0.95%
CompanyEmployeesShares OutstandingFree FloatOptionable
CenterPoint Energy, Inc. stock logo
CNP
CenterPoint Energy
12,500652.73 million650.55 millionOptionable
Entergy Corporation stock logo
ETR
Entergy
11,700430.77 million428.73 millionOptionable
Exelon Co. stock logo
EXC
Exelon
19,1001.01 billion1.00 billionOptionable
Pfizer Inc. stock logo
PFE
Pfizer
83,0005.67 billion5.66 billionOptionable
Seagen Inc. stock logo
SGEN
Seagen
3,256187.70 million139.08 millionOptionable
Zimmer Biomet Holdings, Inc. stock logo
ZBH
Zimmer Biomet
18,000197.84 million197.18 millionOptionable

Recent News About These Companies

Zimmer Biomet Q1 2025 Earnings Preview

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
CenterPoint Energy stock logo

CenterPoint Energy NYSE:CNP

$38.99 +0.39 (+1.01%)
Closing price 05/2/2025 03:59 PM Eastern
Extended Trading
$39.09 +0.10 (+0.26%)
As of 05/2/2025 08:00 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

CenterPoint Energy, Inc. operates as a public utility holding company in the United States. The company operates through two segments, Electric and Natural Gas. The Electric segment includes electric transmission and distribution services to electric customers and electric generation assets, as well as optimizes assets in the wholesale power market. The Natural Gas segment engages in the intrastate natural gas sales, and natural gas transportation and distribution for residential, commercial, industrial and institutional customers in Indiana, Louisiana, Minnesota, Mississippi, Ohio, and Texas; permanent pipeline connections through interconnects with various interstate and intrastate pipeline companies; and provides maintenance and repair services of home appliances to customers in Minnesota and home repair protection plans to natural gas customers in Indiana, Mississippi, Ohio, and Texas through a third party. It serves approximately 2,534,730 metered customers; owned 348 substations with transformer capacity of 79,719 megavolt amperes; and owned and operated 217 miles of intrastate pipeline in Louisiana and Texas. The company was founded in 1866 and is headquartered in Houston, Texas.

Entergy stock logo

Entergy NYSE:ETR

$84.47 +1.10 (+1.32%)
Closing price 05/2/2025 03:59 PM Eastern
Extended Trading
$84.46 -0.01 (-0.01%)
As of 05/2/2025 07:01 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Entergy Corporation, together with its subsidiaries, engages in the production and retail distribution of electricity in the United States. It generates, transmits, distributes, and sells electric power in portions of Arkansas, Louisiana, Mississippi, and Texas, including the City of New Orleans; and distributes natural gas. It also engages in the ownership of interests in non-nuclear power plants that sell electric power to wholesale customers, as well as provides decommissioning services to other nuclear power plant owners. It generates electricity through gas, nuclear, coal, hydro, and solar power sources. The company sells energy to retail power providers, utilities, electric power co-operatives, power trading organizations, and other power generation companies. The company's power plants have approximately 24,000 megawatts of electric generating capacity. It delivers electricity to 3 million utility customers in Arkansas, Louisiana, Mississippi, and Texas. Entergy Corporation was founded in 1913 and is headquartered in New Orleans, Louisiana.

Exelon stock logo

Exelon NASDAQ:EXC

$46.48 -0.12 (-0.26%)
Closing price 05/2/2025 04:00 PM Eastern
Extended Trading
$46.56 +0.08 (+0.17%)
As of 05/2/2025 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Exelon Corporation, a utility services holding company, engages in the energy distribution and transmission businesses in the United States and Canada. The company is involved in the purchase and regulated retail sale of electricity and natural gas, transmission and distribution of electricity, and distribution of natural gas to retail customers. It also offers support services, including legal, human resources, information technology, supply management, financial, engineering, customer operations, transmission and distribution planning, asset management, system operations, and power procurement services. It serves distribution utilities, municipalities, and financial institutions, as well as commercial, industrial, governmental, and residential customers. Exelon Corporation was incorporated in 1999 and is headquartered in Chicago, Illinois.

Pfizer stock logo

Pfizer NYSE:PFE

$24.19 +0.26 (+1.09%)
Closing price 05/2/2025 03:59 PM Eastern
Extended Trading
$24.18 -0.01 (-0.02%)
As of 05/2/2025 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States, Europe, and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic, migraine, and women's health under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral products under the Comirnaty and Paxlovid brands. It also provides medicines and vaccines in various therapeutic areas, such as biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Litfulo, Velsipity, and Cibinqo brands; amyloidosis, hemophilia, endocrine diseases, and sickle cell disease under the Vyndaqel family, Oxbryta, BeneFIX, Somavert, Ngenla, and Genotropin brands; sterile injectable and anti-infective medicines under the Sulperazon, Medrol, Zavicefta, Zithromax, and Panzyga brands; and biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Inlyta, Bosulif, Mektovi, Padcev, Adcetris, Talzenna, Tukysa, Elrexfio, Tivdak, Lorbrena, and Braftovi brands. In addition, the company involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, individual provider offices, retail pharmacies, and integrated delivery systems. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Merck KGaA; and BioNTech SE. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Seagen stock logo

Seagen NASDAQ:SGEN

Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. It offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment of adult patients with advanced or metastatic urothelial cancer; and TUKYSA, an oral small molecule tyrosine kinase inhibitor for the treatment of adult patients with advanced unresectable or metastatic HER2-positive breast cancer. The company also develops TIVDAK for metastatic cervical cancer and other solid tumors; Ladiratuzumab Vedotin, an ADC targeting LIV-1 for metastatic breast cancer and solid tumors; Disitamab Vedotin, a novel HER2-targeted ADC; and SEA-TGT and SEA-CD70 for various cancer diseases. It has collaboration agreements with Takeda Pharmaceutical Company Limited; Agensys, Inc.; Genmab A/S; Merck; and RemeGen, Co. Ltd. The company was formerly known as Seattle Genetics, Inc. and changed its name to Seagen Inc. in October 2020. Seagen Inc. was incorporated in 1997 and is headquartered in Bothell, Washington. As of December 14, 2023, Seagen Inc. operates as a subsidiary of Pfizer Inc.

Zimmer Biomet stock logo

Zimmer Biomet NYSE:ZBH

$102.08 +0.26 (+0.26%)
Closing price 05/2/2025 03:59 PM Eastern
Extended Trading
$102.33 +0.25 (+0.24%)
As of 05/2/2025 06:08 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates as a medical technology company worldwide. The company designs, manufactures, and markets orthopedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, biologics, foot and ankle, extremities, and trauma products; craniomaxillofacial and thoracic products comprising face and skull reconstruction products, as well as products that fixate and stabilize the bones of the chest to facilitate healing or reconstruction after open heart surgery, trauma, or for deformities of the chest. It also offers robotic, surgical, and bone cement products. The company's products and solutions are used to treat patients suffering from disorders of, or injuries to, bones, joints, or supporting soft tissues. It serves orthopedic surgeons, neurosurgeons, hospitals, stocking distributors, healthcare dealers, and other specialists, as well as agents, healthcare purchasing organizations, or buying groups. The company was formerly known as Zimmer Holdings, Inc. and changed its name to Zimmer Biomet Holdings, Inc. in June 2015. Zimmer Biomet Holdings, Inc. was founded in 1927 and is headquartered in Warsaw, Indiana.